• Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Header cover image

U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

High return on equity, past performance and sound balance sheet.

15 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
IRWDIronwood PharmaceuticalsUS$13.499.2%41.6%US$2.2bUS$12.60P/E4.3xE-18.5%n/a
NBIXNeurocrine BiosciencesUS$94.91-0.4%-2.6%US$9.0bUS$122.47P/E24.6xE33.7%n/a
REGNRegeneron PharmaceuticalsUS$619.07-3.4%8.2%US$64.4bUS$681.41P/E10.4xE-6.5%n/a
MEDPMedpace HoldingsUS$191.034.6%73.8%US$6.8bUS$170.50P/E39.1xE12.1%n/a
BIOBio-Rad LaboratoriesUS$766.50-2.0%49.1%US$22.8bUS$771.25P/E5.6xE-41.1%n/a
MRNAModernaUS$408.84-3.4%479.5%US$165.0bUS$307.77P/E47.2xE-48.4%n/a
SAGESage TherapeuticsUS$46.863.6%-21.8%US$2.8bUS$83.05P/E4.1xE25.2%n/a
ABCLAbCellera BiologicsUS$20.991.6%n/aUS$5.8bUS$45.40P/E29.8xE-59.9%n/a
QUREuniQureUS$33.30-9.1%-8.5%US$1.5bUS$66.30P/E5.1xE-50.7%n/a
BPMCBlueprint MedicinesUS$106.361.1%19.7%US$6.2bUS$119.00P/E18.3xE56.2%n/a
BDSIBioDelivery Sciences InternationalUS$3.74-3.9%-0.8%US$368.8mUS$7.32P/E10.9xE38.2%n/a
CPRXCatalyst PharmaceuticalsUS$5.197.0%64.2%US$534.5mUS$8.30P/E7.2xE8.4%n/a
SIGASIGA TechnologiesUS$7.219.4%2.0%US$541.3mn/aP/E12.4xE18.0%n/a
ATRSAntares PharmaUS$3.783.0%37.5%US$642.5mUS$6.64P/E9.9xE28.4%n/a
MRMDMariMedUS$0.93-0.9%487.3%US$306.6mUS$2.25P/E17.5xE20.1%n/a
Page 1 of 1